| Shareholder | |||||
|---|---|---|---|---|---|
Rosalind Advisors, Inc. | 13.55% | 701.69K | 8.69% | +450.18K | |
Rosalind Advisors, Inc. | 13.55% | 701.69K | 8.69% | +450.18K | |
CHL Medical Partners | 12.56% | 650.42K | 0.00% | +0 | |
CHL Medical Partners | 12.56% | 650.42K | 0.00% | +0 | |
Haisco Pharmaceutical Group Co., Ltd. | 11.91% | 616.61K | 0.00% | +0 | |
Haisco Pharmaceutical Group Co., Ltd. | 11.91% | 616.61K | 0.00% | +0 | |
Vitalife Partners | 7.74% | 400.94K | <0.01% | +1.00 | |
Vitalife Partners | 7.74% | 400.94K | 0.00% | +0 | |
Ocorian Fund Management S.à R.L. | 5.72% | 296.37K | 0.00% | +0 | |
Ocorian Fund Management S.à R.L. | 5.72% | 296.37K | 0.00% | +0 | |
DSM-Firmenich AG | 5.04% | 261.02K | 0.00% | +0 | |
DSM-Firmenich AG | 5.04% | 261.02K | 0.00% | +0 | |
Pini Ben-ElazarIndependent Director | 2.48% | 128.67K | -- | +128.67K | |
Pini Ben-ElazarIndependent Director | 2.48% | 128.67K | 0.00% | +0 | |
Medica Venture Partners | 2.40% | 124.09K | 0.00% | +0 | |
Medica Venture Partners | 2.40% | 124.09K | 0.00% | +0 | |
Warberg Asset Management LLC | 1.68% | 86.98K | 1.68% | +86.98K | |
Warberg Asset Management LLC | 1.68% | 86.98K | 1.68% | +86.98K | |
Jane Street Group, LLC | 0.84% | 43.33K | -- | +43.33K | |
Renaissance Technologies LLC | 0.26% | 13.35K | -- | +13.35K |
